tth/pca

CASE PRESENTATION A 64-year-old healthy man presented with prostate cancer diagnosed in 2016. The pathology showed Gleason scores 3+3 and 3+4 in multiple cores and the patient underwent an uncomplicated radical prostatectomy. He regained urinary continence; however, he required injection...

Abraham Morgentaler, MD, FACS, summarizes results from a study on testosterone therapy for patients with advanced prostate cancer.

ABSTRACT Background: Physician prescribing patterns surrounding the use of testosterone therapy (TTh) in men with a history of prostate cancer (CaP) is not well described. Aim: To characterize the demographics and usage patterns of testosterone therapy in men with a history of prostate cancer...

ABSTRACT Introduction: Although testosterone therapy (TTh) is the standard practice in otherwise healthy hypogonadal men, this therapy has historically been contraindicated in men with a history of prostate cancer. Recent evidence suggests that there is minimal or no prostate cancer growth in...